tbuckley/cabot-search huggingface dataset:
Error in SI Conversion.
Journal: JAMA (1994)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Good health care for the aged
Authors: D. C. Kennie
Journal: JAMA (1983)

Despite the recent upsurge of interest in geriatrics, relatively little guidance has been given on what constitutes good health care for the aged. Ten basic principles for good health care are outlined. They include emphasis on the restoration of functional ability; the building and maintenance of a support system; a broadened approach to health assessment; the application of specific medical knowledge and skills; cautious medical intervention; true advocacy for the patient; the acceptance of the legitimacy of death; increased community orientation; the allowance of sufficient time for recovery; and continuity of care. These principles should serve as the basis for educational, research, and service programs for the aged. (<i>JAMA</i>1983;249:770-773)
Infusion of floxuridine in the treatment of solid tumors
Authors: R. J. Papac
Journal: JAMA (1966)

Thirty-two patients with far advanced neoplastic diseases were treated with floxuridine therapy by continuous infusion. Three of 19 patients with gastrointestinal neoplasms obtained a response to treatment and four additional patients had a beneficial effect from therapy. Four of five patients with carcinoma of the breast had a response to the drug and in two of these, the duration of the response exceeded a year. These results were achieved with minimal associated side effects.
Government
Authors: Judith Feder
Journal: JAMA (1992)

From the congressional perspective, the past year has been dominated by implementing and monitoring previously enacted legislation and planning for future legislative action. The changes enacted as part of the Omnibus Budget Reconciliation Act of 1990 were negotiated to stand as the savings initiatives in Medicare and Medicaid for 3 years, thus removing these programs from the annual deficit reduction legislation.<sup>1</sup>In the absence of budget-cutting legislation, congressional attention turned to monitoring the implementation of legislation on Medicare payment of physicians and hospital capital and regulating Medicaid provider taxes and donations. Implementation of the regulations was not without controversy between the administration and the authorizing committees in Congress. Draft physician payment regulations in June sparked a major controversy over the levels of the conversion factors to be used in implementing the resource-based, relative value fee schedule for Medicare. Oversight hearings were held in the three committees of jurisdiction, resulting
Eczema. A Consideration of Its Course, Diagnosis and Treatment Embracing Many Points of Practical Importance, and Containing 146 Prescriptions, Illustrating Dosage In Local Applications.
Journal: JAMA (1906)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Racial differences in heart failure presentation but not therapy: Report from the UNITE-HF multicenter heart failure database Hector O. Ventura, Ron M. Oren, Jalal K. Ghali, Mandeep R. Mehra, Ileana Pina, Daniel J. Lenihan, Alan B. Miller, Grady Hendrix, Wendy A. Gattis, Sirisha Mallemala, Christopher M. O'Connor, Kirkwood F. Adams, Jr., for the UNITE-HF Investigators. University of North Carolina, Chapel Hill, NC
Journal: Journal of the American College of Cardiology (2001)
Methylxanthines
Authors: Paul Goldenheim
Journal: Annals of Internal Medicine (1990)

Letters and Corrections1 January 1990MethylxanthinesPaul Goldenheim, MDPaul Goldenheim, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-112-1-74_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editor: Dr. Rossing's editorial (1), "Methylxanthines in 1989," raises some concerns as he concludes that:although theophylline remains useful in a few clinical situations, it is no longer the mainstay in the treatment of airway obstruction. It seems likely that theophylline use will decline further as clinicians continue to adopt inhaled bronchodilators and anti-inflammatory drugs as first-line therapy.I am concerned that Dr. Rossing arrives at these conclusions largely from observations in severe, acute asthma and extends these findings to asthma therapy in general. Acute attacks are a component of this disease; however, the therapeutic approach involves strategies...References1. Rossing T. Methylxanthines in 1989. Ann Intern Med. 1989;110:502-4. LinkGoogle Scholar2. McFadden E Reports. In: , ed. Asthma: A Nocturnal Disease. Proceedings of a Symposium. Am J Med. 1988;85:(1B). Google Scholar3. Pauwels R. New aspects of the therapeutic potential of theophylline in asthma. J Allergy Clin Immunol. 1989;83:548-53. CrossrefMedlineGoogle Scholar4. JoadAhrensLindgrenWeinberger JRSM. Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma. J Allergy Clin Immunol. 1987;79:78-85. CrossrefMedlineGoogle Scholar5. ArkinstallAtkinsHarrisonStewart WMDJ. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics. Am Rev Resp Dis. 1987;135:316-21. MedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Paul Goldenheim, MDAffiliations: The Purdue Frederick Company Norwalk, CT 06856 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 January 1990Volume 112, Issue 1Page: 74-74KeywordsAsthmaDrug therapyInhaled bronchodilatorMethylxanthine ePublished: 1 December 2008 Issue Published: 1 January 1990 PDF downloadLoading ...
Computers and clinicians
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
IDENTIFICATION OF CRIMINALS.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Coping with tuberculosis in a prison population
Journal: JAMA (1981)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THU0031 Anti-Carbamylated Protein Antibodies (Anti-CarP) Precede the Onset of Rheumatoid Arthritis
Authors: J. Shi, L. van de Stadt, N. Levarht, T. Huizinga, D. Hamann, D. van Schaardenburg, R. Toes, L. Trouw
Journal: Annals of the Rheumatic Diseases (2013)

<h3>Background</h3> Anti-citrullinated protein antibodies (ACPA) and IgM-Rheumatoid Factor (IgM-RF) are auto-antibodies that can be detected many years before the clinical diagnosis of Rheumatoid Arthritis (RA) [1]. Since ACPA and IgM-RF are known as predictive and prognostic markers of RA, it is conceivable that these antibodies play a pathogenic role in RA. In recent studies we discovered anti-carbamylated protein (anti-CarP) antibodies as a prognostic marker in RA [2]. In addition anti-CarP antibodies are associated with a conversion to RA in patients that suffer from arthralgia [3]. <h3>Objectives</h3> In this study we analyzed whether anti-CarP antibodies can also be detected prior to the onset of the symptoms of RA and which auto-antibody appears first over time. <h3>Methods</h3> Sera of 79 RA patients prior to the onset of symptoms and 141 age and sex matched controls that were regular blood donors were tested for the presence of anti-carbamylated fetal calf serum (Ca-FCS) antibodies, anti-carbamylated fibrinogen (Ca-Fib) antibodies, anti-cyclic citrullinated peptide 2 (CCP2) antibodies and RF-IgM. A median of 6 (IQR 4-9) sequential pre-RA sera, obtained at 1-2 year intervals was available for analysis. <h3>Results</h3> Anti-CarP antibodies were present in 39% of the serum samples that were drawn just prior to the diagnosis of RA of blood donors compared to 4% of the matched control samples. Anti-CarP antibodies were present in both ACPA positive and ACPA negative patients. Of the 79 individuals that developed RA, 42% were positive for anti-CCP2 antibodies and 24% for IgM RF. Analysis of the longitudinal samples revealed that anti-CarP antibodies could be detected many years before the onset of symptoms (median 8 years). Comparing the first appearance of the three autoantibody families revealed that both ACPA and anti-CarP antibodies appear (similarly) earlier in time as compared to IgM-RF. <h3>Conclusions</h3> Next to ACPA and IgM-RF also the newly identified anti-CarP antibodies appear many years before the onset of clinical symptoms of RA. <h3>References</h3> Nielen MM, <i>et al</i>. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004; 50:380-6. Shi J, <i>et al</i>. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc.Natl.Acad.Sci.U.S.A 2011; 108:17372-7. Shi J, <i>et al</i>. Anti Carbamylated Protein Antibodies (anti-CarP) are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum. 2012. <h3>Acknowledgements</h3> L.A.T. receives a fellowship from Janssen Biologics BV, (Johnson &amp; Johnson) <h3>Disclosure of Interest</h3> None Declared
8P Cdk4/6 inhibitor activity in metastatic bladder cancer cell lines is independently of RB1 status
Authors: D. Castellano, C. Rubio, F. López-Calderón, C. Segovia, M. Dueñas, M. Martinez-Fernández, I. Otero, R. Manneh, G. De Velasco, J. Paramio
Journal: Annals of Oncology (2016)
PLASMA PROTEINS IN NEPHRITIS
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Some comments on the occasion of the 1967 Passano Award to Dr. Irvine Page
Authors: J. A. Shannon
Journal: JAMA (1967)

It is a great pleasure for me to be with you and to have an opportunity to comment on the accomplishments and talents of Dr. Irvine Page, a distinguished scientist and physician. You will not be surprised if I talk briefly on some aspects of hypertension and atherosclerosis. Our increasing understanding of these diseases and the scientific contributions of Dr. Page are intimately entwined and interdependent. But I will talk about the diseases in a very general way and only touch lightly upon Dr. Page's role in their exploration. Three major points might be made: (1) These are important diseases. These and immediately related diseases continue to account for about half of all deaths in the United States. (2) Substantial progress has been made in clarifying both their nature and their management. (3) Finally, our considerations at this meeting can be viewed as a brief pause at a way station
Bureau of Legal Medicine and Legislation
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Diagnostic Testing and Immunotherapy for Allergy-Reply
Journal: JAMA (1988)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Oncology nurse facilitated supportive care for new cancer patients in a community teaching hospital
Authors: R. W. Frelick
Journal: Journal of Clinical Oncology (2004)

8135 Background: A 1999 cancer patient exit survey found frequent patient confusion and distress about the complicated multi-physician, laboratory, and imaging pathway needed for management of cancers. In response, Christiana Hospital developed a plan to assigned an experienced oncology nurse to each newly identified cancer patient, whether an inpatient or outpatient, starting in Jan 2000. Methods: Physicians were presuaded that patients would benefit by recruiting oncology nurses to support and to effectively and efficiently arrange appointments to also reduce the time from diagnosis to treatment. Nurses were assigned by the type of cancer, and to oncologists while stimulating significant nurse leadership to assure communication between social workers, and other support staff including 14 research protocol and 4 outreach nurses with screeing and outpatient follow up services. They also recorded previously designated measures to evaluate current and ongoing steps for patient management. Results: After 14 quarters the time from diagnosis to biopsy dropped from 10.2 to 7.3 days for breast cancers with a high (97.2%) patient satisfaction rating while the number of patients increased from 139 in '99 to 5061 by August '03. That involved 8 nurses working with 12 multidisciplinary centers and individual physicians. National research clinical trials accruals rose from 6.4% of analytic patients to 13.4%, and subjects from 140 to 344. Surveys also showed high levels of satisfaction among nurses and physicians even before moving many offices and services to a central cancer center building in the middle of 2002. Conclusions: The oncology nurse facilitated supporting care helped decrease the time from diagnosis to breast biopsy, increase patient satisfaction ratings and increased accruals to research protocols. No significant financial relationships to disclose.
Anticoagulation in liver transplant candidates: a case control study
Authors: Domitille Erard-Poinsot, Jeanne-Marie Giard, Willems Philippe, Alissa Chehade, Bergere Michel, Marc Bilodeau, Catherine Vincent, Julien Bissonnette, Jérôme Dumortier, Genevieve Huard
Journal: Journal of Hepatology (2020)
Cheap and effective method of weighing bed-bound patients
Authors: D. T Hansell, G. D Smellie
Journal: BMJ (1982)

Death due to overdose of indoraminIndoramin (Baratol) is a recently introduced alpha'-adrenergic antagonist used to treat essential hypertension.I report a fatal case of self-poisoning with indoramin.This is the first such case to be de- scribed.
HIV-1 antibody testing
Authors: L. W. Kitchen
Journal: JAMA (1988)

<h3>To the Editor.—</h3> Schwartz et al<sup>1</sup>recently presented in<i>JAMA</i>a comprehensive summary of the current status of human immunodeficiency virus (HIV) serum antibody testing. However, two points raised by the authors concerning HIV-1 antibody testing by enzyme-linked immunoassay (EI A) warrant further comment. The authors state that "the more reactive the HIV test result, the greater the likelihood of disease. Most false-positive EI A results occur in specimens that have a low specimen-to-control optical density ratio." I suggest that it would be more accurate to say that "the higher the absorbance value corresponding to HIV-1 antibody level, the greater the likelihood of minimally symptomatic HIV-1 infection," since loss of antibody to<i>gag-</i>encoded HIV-1 proteins is frequently associated with development of HIV-related disease among persons in the developed world and may complicate serodiagnosis.<sup>2</sup>I agree that a highly reactive EIA is more likely to represent a true-positive